Suggestions

Du même auteur

Daratumumab is effective in the relapsed or refractory systemic light-chain amyloidosis but associated with high infection burden in a frail real-life population.

Archive ouverte | van de Wyngaert, Zoé | CCSD

International audience

Letter to the editor Resolution of bortezomib-associated chalazia/blepharitis after switch to ixazomib: a case report

Archive ouverte | Lemoine, Jean | CCSD

International audience

Combination of brentuximab‐vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T‐cell lymphoma

Archive ouverte | van de Wyngaert, Zoé | CCSD

International audience. ObjectivesRelapsed/refractory peripheral T‐cell lymphomas (PTCL) have a poor prognosis. We aimed at assessing efficacy of ifosfamide, carboplatin, etoposide (ICE) regimen, a known therapeutic...

Chargement des enrichissements...